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Introduction 
Non-occlusive mesenteric ischemia 
(NOMI) is an acute mesenteric circulatory 
disorder that, in contrast to mesenteric 
arterial occlusion induced by blockage of 
blood flow by emboli and thrombi, is not 
caused by organic occlusion of blood 
vessels.1  Good outcomes in NOMI are 
observed with early recognition and 
treatment.1-2  The early symptoms and 
characteristics of NOMI, however, are 
unclear.  In many cases, the disease has 
advanced to an irreversible stage before a 
definite diagnosis is made.  
 
Case Report 
A 59-year-old female presented with 
congestive heart failure, secondary to 
ischemic heart disease.  She reported a two-
day history of profuse watery diarrhea with 
mild cramping abdominal pain starting 30 
minutes after eating and improving 
intermittently between meals. She had 
complained over four months of nausea and 
vomiting that had increased in frequency 
and of a 20-pound weight loss.  She has 
been compliant with her medications and 
no new changes have been made within the 
last six months. 
On physical exam, she was hypotensive 
with mild diffuse abdominal tenderness. 
The laboratory investigation showed a high 
white blood count of 25,000 with a 
bandemia of 22%.  
Mesenteric ischemia was suspected and 
a  CT  scan  of her abdomen showed diffuse  
 
 
thickened small bowel loops (Figure 1).  A 
CT angiogram of her abdomen revealed 
patent mesenteric vessels (Figure  2). 
 
 
Figure 1.  CT scan of the abdomen showed 
diffuse thickening of small bowel loops. 
 
   
Figure 2. CT angiogram with 3-dimentional 
reconstruction showed patent mesenteric 
vessels. 
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A colonoscopy (Figure 3) showed 
necrosis from the anal margin to the left 
splenic margin, necrosis of the cecum and 
terminal ileum with preserved mucosa of 
the transverse and right colon consistent 
with a diagnosis of NOMI.  
The patient went into septic shock and 
expired after one day.  
 
 
Figure 3. (A - B) Colonoscopy at the level 
of the sigmoid and splenic flexure showed 
a pale mucosal with diffuse ischemia, 
scattered shallow irregular ulcerations, 
longitudinal and irregular in form with 
gray-yellow exudates.  (C) A diffuse 
ischemic mucosa of the colon is seen with 
overlying exudates at the hepatic flexure. 
 
Discussion 
NOMI is the result of splanchnic 
vasoconstriction occurring in response to a 
variety of systemic insults that diminish 
mesenteric blood flow.1,3  The macro-
vasculature is patent, but the microvascular 
blood flow is inadequate to meet intestinal 
tissue demands leading to gangrene.  The 
consequences are disastrous and the 
prognosis is very poor, despite the absence 
of organic obstruction in the principal 
arteries.1,4  NOMI accounts for more than 
10% to 20% of cases of acute mesenteric 
circulatory disorders, mainly in elderly 
patients, with a mortality rate of 70% to 
90%.2-3  
The pathophysiology of NOMI involves 
low blood flow states such as shock, heart 
failure, hemodialysis, and direct splanchnic 
arteriolar vasoconstriction by drugs (e.g., 
digoxin).2-3,5  Intestinal vasospasm due to 
persistent low perfusion is thought to be the 
inciting factor. NOMI can present with 
abdominal pain, nausea, vomiting, and 
ileus, but the characteristic early symptoms 
and laboratory test results are unclear. 
Early diagnosis is difficult and during the 
diagnostic process the disease slowly 
advances to an irreversible state with 
extensive intestinal necrosis. 2,4-5 
Angiography is the gold standard for 
diagnosis.  Its invasive nature and potential 
for contrast nephropathy, however, makes 
angiography a less than optimal screening 
tool, thereby missing the opportunity for 
resolution in many cases.1-2,5 For definite 
diagnosis, the absence of organic 
obstruction of blood vessels distributed in 
the necrotic intestinal region and 
segmented discontinuous intestinal and 
colonic ischemic changes with necrosis on 
colonoscopy or laparotomy are required.3-4 
However, the time required for definite 
diagnosis may compromise the chances of 
survival.3 
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The endoscopic feature in NOMI is 
segmental distribution with a clear 
boundary between the injured and 
uninvolved region. The lesions could range 
from marked edematous mucosa with loss 
of clear vascular vessel pattern to scattered 
shallow irregular ulcerations, longitudinal 
or irregular in form, with gray-yellow 
exudates.8 
The role of colonoscopy is limited to 
the evaluation of the mucosal severities and 
the extent of the disease.  It may be helpful 
in predicting clinical status and the 
prognosis of the patients.6-8  It is safe and 
helpful in the early phase but should be 
performed with great care because 
increased pressures from insufflations 
could induce new ischemic lesions.7-8 
Recently, abdominal contrast multi-
detector row computed tomography upon 
suspicion of NOMI has emerged enabling a 
rapid definite diagnosis and providing 
vascular information comparable to that 
obtained in angiography. It permits 
subsequent early initiation of therapy and 
monitoring of disease resolution.1,9 
The initial treatment is to correct 
predisposing or precipitating causes.  Relief 
of acute congestive heart failure, correction 
of unstable or new cardiac arrhythmias, and 
replacement of blood volume should 
precede any diagnostic studies.3-4  The 
main goal of current therapy for NOMI is 
reduction of spasm and improved perfusion 
of the mesenteric artery mainly with 
continuous administration of vasodilators 
into the mesenteric artery such as 
papaverine, prostaglandin E1, and 
nitroglycerine. The role of surgery is 
limited to diagnostic laparotomy and 
excision of irreversibly necrotized 
intestine.3,10 
 
Conclusion 
NOMI is increasingly more common 
due to the aging of the population, but the 
disease concept has not been established 
fully. Moreover, NOMI is difficult to 
diagnose, lacks characteristic symptoms, 
and is fatal in the advanced stage.  
Therefore, many patients may not have 
been diagnosed correctly and consequently 
may have died without receiving adequate 
treatment.  Prognosis is related to the time 
of treatment initiation.  Early diagnosis in 
suspected cases and early initiation of 
treatment may increase survival of NOMI 
patients. 
 
References 
1
 Yasuhara H.  Acute mesenteric ischemia: 
The challenge of gastroenterology. Surg 
Today 2005; 35:185-195. 
2
 Acosta S, Ogren M, Sternby NH, 
Berqvist D, Björck M. Fatal nonocclusive 
mesenteric ischemia: Population-based 
incidence and risk factors. J Intern Med 
2006; 259:305-313.  
3
 Bassiounty HS. Nonocclusive mesenteric 
ischemia. Surg Clin North Am 1997; 
77:319-326. 
4
 Lock G, Schölmerich J. Nonocclusive 
mesenteric ischemia. Hepato-
gastroenterology 1995; 42:234-239. 
5
 Brandt LJ, Boley SJ. Nonocclusive 
mesenteric ischemia.  Annu Rev Med 
1991; 42:107-117. 
6
 Wheeldon NM, Grundman MJ. Ischemic 
colitis as a complication of colonoscopy. 
BMJ 1990; 301:1080-1081. 
7
 Ryu KH, Shim K, Kim S, et al. The 
usefulness of colonoscopy in ischemic 
colitis. Gastrointest Endosc 2006; 
63:AB212.  
8
 Yang XS, Lu YM, Yu CF, Wang CW. 
Clinical and endoscopic features of 
ischemic colitis. Chin J of Dig Dis 2003; 
4:64-68. 
9
 Mitsuyoshi A, Obama K, Shinkura N, Ito 
T, Zaima M.  Survival in nonocclusive 
mesenteric ischemia:  Early diagnosis by 
multidetector row computed tomography 
and early treatment with continuous 
Kansas Journal of Medicine 2008                                                     Non-Occlusive Mesenteric Ischemia 
 52 
intravenous high-dose prostaglandin E(1). 
Ann Surg 2007; 246:229-235. 
10
 Kang H, Manasia A, Rajamani S, et al. 
Intravenous iloprost increases mesenteric 
blood flow in experimental acute 
nonocclusive mesenteric ischemia. Crit 
Care Med 2002; 30:2528-2534. 
 
Keywords:  mesenteric ischemia, non-
occlusive mesenteric ischemia, ischemic 
colitis, endoscopy, colonoscopy. 
 
